Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a ...

China's emergence as a second hub of pharmaceutical innovation could trigger massive changes to the global drug market, ...

The collaborations will use Simulations Plus software platforms, including ADMET Predictor, GastroPlus, Thales, and ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

OnKure Therapeutics Inc. (Nasdaq: OKUR), a Boulder precision-oncology company that went public in 2024 via a merger with California-based Reneo Pharmaceuticals Inc., expects to raise about $150 ...

To study this transformation, we compile a comprehensive, synchronized database spanning the pharmaceutical drug development supply chain, covering scientific publications, clinical trials, drug ...

"A new Pulse Report from BCC Research, AI Impact on Neuroprotective Agents, provides a comprehensive analysis of how AI is ...

Kelly Chibale says that the hunt for new drugs is kind of like a fairy-tale quest. And it takes a lot of time and patience.

It’s always a high-stakes gamble in the pharmaceutical industry to develop a new drug. The process typically takes 10 to 15 years and requires extensive testing, regulatory approval, and clinical ...

Ebrahimi is a scientific leader at GSK. Mrksich is the Henry Wade Rogers professor at Northwestern University, where he is developing the MegaMolecule technology for creating multifunctional ...

There has been much discussion recently about how artificial intelligence and machine learning (AI/ML) will revolutionize pharmaceutical research. Substantial progress has been made in the discovery ...

Respiratory infectious diseases, such as viral pneumonia, pose a serious threat to global public health. These diseases spread rapidly and widely, potentially causing severe complications such as ...